Abstract
Epidemiological studies provide strong evidence that obstructive sleep apnea (OSA) is associated with cardiovascular complications such as systemic hypertension, congestive heart failure, and atrial fibrillation. Successful OSA treatment with continuous positive airway pressure (CPAP) has resulted in coincident reductions in systemic hypertension, improvements in left ventricular systolic function, and reductions in sympathetic nervous activity. These data suggest that successful treatment of OSA may reduce cardiovascular morbidity in such patients. Although CPAP is the more successful treatment for OSA when used properly and consistently, its clinical success is often limited by poor patient and partner acceptance, which leads to suboptimal compliance. Oral appliances or upper airway surgeries are considered a second line of treatment for patients with mild to moderate OSA who do not comply with or refuse long-term CPAP treatment. Oral devices such as mandibular repositioning appliances were recently shown to improve arterial hypertension in OSA patients. Electrical stimulation of the hypoglossal nerve is a new investigational therapy for patients with moderate to severe OSA. This new treatment option, if proven effective, may provide cardiovascular benefits secondary to treating OSA.
Similar content being viewed by others
References
American Academy of Sleep Medicine Task Force (1999). Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep, 22, 667–689.
Young, T., Palta, M., Dempsey, J., et al. (1993). The occurrence of sleep-disordered breathing among middle-aged adults. The New England Journal of Medicine, 328, 1230–1235.
Bradley, T. D., & Floras, J. S. (2003). Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation, 107, 1671–1678.
Bradley, T. D., & Floras, J. S. (2009). Obstructive sleep apnoea and its cardiovascular consequences. Lancet, 373, 82–93.
Somers, V. K., White, D. P., Amin, R., et al. (2008). Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council On Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing in collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation, 118, 1080–1111.
Stoohs, R., & Guilleminault, C. (1992). Cardiovascular changes associated with obstructive sleep apnea syndrome. Journal of Applied Physiology, 72, 583–589.
Dyugovskaya, L., Lavie, P., & Lavie, L. (2002). Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. American Journal of Respiratory and Critical Care Medicine, 165, 934–939.
Ryan, S., Taylor, C. T., & McNicholas, W. T. (2005). Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation, 112, 2660–2667.
Brooks, D., Horner, R. L., Kozar, L. F., et al. (1997). Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. Journal of Clinical Investigation, 99, 106–109.
Narkiewicz, K., Montano, N., Cogliati, C., et al. (1998). Altered cardiovascular variability in obstructive sleep apnea. Circulation, 98, 1071–1077.
Chan, A. S., & Cistulli, P. A. (2009). Oral appliance treatment of obstructive sleep apnea: an update. Current Opinion in Pulmonary Medicine, 15, 591–596.
Randerath, W. J., Heise, M., Hinz, R., et al. (2002). An individually adjustable oral appliance vs continuous positive airway pressure in mild-to-moderate obstructive sleep apnea syndrome. Chest, 122, 569–575.
Marin, J. M., Carrizo, S. J., Vicente, E., et al. (2005). Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 365, 1046–1053.
Selim, B., Won, C., & Yaggi, H. K. (2010). Cardiovascular consequences of sleep apnea. Clinics in Chest Medicine, 31, 203–220.
Chobanian, A. V., Bakris, G. L., Black, H. R., et al. (2003). Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension, 42, 1206–1252.
Bixler, E. O., Vgontzas, A. N., Lin, H. M., et al. (2000). Association of hypertension and sleep-disordered breathing. Archives of Internal Medicine, 160, 2289–2295.
Peppard, P. E., Young, T., Palta, M., et al. (2000). Prospective study of the association between sleep-disordered breathing and hypertension. The New England Journal of Medicine, 342, 1378–1384.
Nieto, F. J., Young, T. B., Lind, B. K., et al. (2000). Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. Jama, 283, 1829–1836.
O’Connor, G. T., Caffo, B., Newman, A. B., et al. (2009). Prospective study of sleep-disordered breathing and hypertension: the sleep heart health study. American Journal of Respiratory and Critical Care Medicine, 179, 1159–1164.
Lloyd-Jones, D. M., Larson, M. G., Leip, E. P., et al. (2002). Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation, 106, 3068–3072.
Shahar, E., Whitney, C. W., Redline, S., et al. (2001). Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. American Journal of Respiratory and Critical Care Medicine, 163, 19–25.
Mehra, R., Benjamin, E. J., Shahar, E., et al. (2006). Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. American Journal of Respiratory and Critical Care Medicine, 173, 910–916.
Wang, H., Parker, J. D., Newton, G. E., et al. (2007). Influence of obstructive sleep apnea on mortality in patients with heart failure. Journal of the American College of Cardiology, 49, 1625–1631.
Sin, D. D., Fitzgerald, F., Parker, J. D., et al. (1999). Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. American Journal of Respiratory and Critical Care Medicine, 160, 1101–1106.
Lloyd-Jones, D. M., Wilson, P. W., Larson, M. G., et al. (2004). Framingham risk score and prediction of lifetime risk for coronary heart disease. The American Journal of Cardiology, 94, 20–24.
Somers, V. K., Dyken, M. E., Clary, M. P., et al. (1995). Sympathetic neural mechanisms in obstructive sleep apnea. Journal of Clinical Investigation, 96, 1897–1904.
Chou, C. C., & Chen, P. S. (2008). New concepts in atrial fibrillation: mechanism and remodeling. The Medical Clinics of North America, 92, 53–63.
Condos, W. R., Jr., Latham, R. D., Hoadley, S. D., et al. (1987). Hemodynamics of the mueller maneuver in man: right and left heart micromanometry and doppler echocardiography. Circulation, 76, 1020–1028.
Hall, M. J., Ando, S., Floras, J. S., et al. (1998). Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. Journal of Applied Physiology, 85, 1476–1484.
Drager, L. F., Bortolotto, L. A., Pedrosa, R. P., et al. (2010). Left atrial diameter is independently associated with arterial stiffness in patients with obstructive sleep apnea: potential implications for atrial fibrillation. International Journal of Cardiology, 144(2), 257–259.
Franz, M. R., & Bode, F. (2003). Mechano-electrical feedback underlying arrhythmias: the atrial fibrillation case. Progress in Biophysics and Molecular Biology, 82, 163–174.
Shamsuzzaman, A. S., Winnicki, M., Lanfranchi, P., et al. (2002). Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation, 105, 2462–2464.
Chung, M. K., Martin, D. O., Sprecher, D., et al. (2001). C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation, 104, 2886–2891.
Guilleminault, C., Connolly, S. J., & Winkle, R. A. (1983). Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. The American Journal of Cardiology, 52, 490–494.
Gami, A. S., Pressman, G., Caples, S. M., et al. (2004). Association of atrial fibrillation and obstructive sleep apnea. Circulation, 110, 364–367.
Gami, A. S., Hodge, D. O., Herges, R. M., et al. (2007). Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. Journal of the American College of Cardiology, 49, 565–571.
Sullivan, C., Issa, F., Berthon-Jones, M., et al. (1981). Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet, 1, 862.
Ballester, E., Badia, J. R., Hernandez, L., et al. (1999). Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. American Journal of Respiratory and Critical Care Medicine, 159, 495–501.
Giles, T. L., Lasserson, T. J., Smith, B. H., et al. (2006). Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database of Systematic Reviews, 3, CD001106.
Gordon, P., & Sanders, M. H. (2005). Sleep. 7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome. Thorax, 60, 68–75.
Montserrat, J. M., Ferrer, M., Hernandez, L., et al. (2001). Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. American Journal of Respiratory and Critical Care Medicine, 164, 608–613.
Amfilochiou, A., Tsara, V., Kolilekas, L., et al. (2009). Determinants of continuous positive airway pressure compliance in a group of Greek patients with obstructive sleep apnea. European Journal of Internal Medicine, 20, 645–650.
De Backer, W. (1998). Non-CPAP treatment of obstructive sleep apnoea. Monaldi Archives for Chest Disease, 53, 625–629.
Grote, L., Hedner, J., Grunstein, R., et al. (2000). Therapy with nCPAP: incomplete elimination of sleep related breathing disorder. The European Respiratory Journal, 16, 921–927.
Lindberg, E., Berne, C., Elmasry, A., et al. (2006). CPAP treatment of a population-based sample—what are the benefits and the treatment compliance? Sleep Medicine, 7, 553.
Duran-Cantolla, J., Aizpuru, F., Martinez-Null, C., et al. (2009). Obstructive sleep apnea/hypopnea and systemic hypertension. Sleep Medicine Reviews, 13, 323–331.
McNicholas, W. T. (2007). Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 293, R1666–R1670.
Bazzano, L. A., Khan, Z., Reynolds, K., et al. (2007). Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension, 50, 417–423.
Haentjens, P., Van Meerhaeghe, A., Moscariello, A., et al. (2007). The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Archives of Internal Medicine, 167, 757–764.
Mayer, J., Becker, H., Brandenburg, U., et al. (1991). Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology, 79, 84–92.
Sanner, B. M., Tepel, M., Markmann, A., et al. (2002). Effect of continuous positive airway pressure therapy on 24-hour blood pressure in patients with obstructive sleep apnea syndrome. American Journal of Hypertension, 15, 251–257.
Shivalkar, B., Van de Heyning, C., Kerremans, M., et al. (2006). Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. Journal of the American College of Cardiology, 47, 1433–1439.
Martinez-Garcia, M. A., Gomez-Aldaravi, R., Soler-Cataluna, J. J., et al. (2007). Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. The European Respiratory Journal, 29, 951–957.
Brotman, D. J., Davidson, M. B., Boumitri, M., et al. (2008). Impaired diurnal blood pressure variation and all-cause mortality. American Journal of Hypertension, 21, 92–97.
Barbe, F., Duran-Cantolla, J., Capote, F., et al. (2010). Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. American Journal of Respiratory and Critical Care Medicine, 181, 718–726.
Kaneko, Y., Floras, J. S., Usui, K., et al. (2003). Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. The New England Journal of Medicine, 348, 1233–1241.
Mansfield, D. R., & Naughton, M. T. (2004). Sleep apnea and congestive heart failure. Minerva Medica, 95, 257–280.
Kanagala, R., Murali, N. S., Friedman, P. A., et al. (2003). Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation, 107, 2589–2594.
Lavie, P., Lavie, L., & Herer, P. (2005). All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. The European Respiratory Journal, 25, 514–520.
Yaggi, H. K., Concato, J., Kernan, W. N., et al. (2005). Obstructive sleep apnea as a risk factor for stroke and death. The New England Journal of Medicine, 353, 2034–2041.
Young, T., Finn, L., Peppard, P. E., et al. (2008). Sleep disordered breathing and mortality: eighteen-year follow-up of the wisconsin sleep cohort. Sleep, 31, 1071–1078.
Marshall, N. S., Wong, K. K., Liu, P. Y., et al. (2008). Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep, 31, 1079–1085.
Chan, A. S., & Cistulli, P. A. (2009). Oral appliance treatment of obstructive sleep apnea: an update. Current Opinion in Pulmonary Medicine. (in press).
McArdle, N., Devereux, G., Heidarnejad, H., et al. (1999). Long-term use of cpap therapy for sleep apnea/hypopnea syndrome. American Journal of Respiratory and Critical Care Medicine, 159, 1108–1114.
Weaver, T. E., Kribbs, N. B., Pack, A. I., et al. (1997). Night-to-night variability in cpap use over the first 3 months of treatment. Sleep, 20, 278–283.
Vanderveken, O. M., Devolder, A., Marklund, M., et al. (2008). Comparison of a custom-made and a thermoplastic oral appliance for the treatment of mild sleep apnea. American Journal of Respiratory and Critical Care Medicine, 178, 197–202.
Ferguson, K. A., Cartwright, R., Rogers, R., et al. (2006). Oral appliances for snoring and obstructive sleep apnea: a review. Sleep, 29, 244–262.
Kushida, C. A., Morgenthaler, T. I., Littner, M. R., et al. (2006). Practice parameters for the treatment of snoring and obstructive sleep apnea with oral appliances: an update for 2005. Sleep, 29, 240–243.
Cistulli, P. A., Gotsopoulos, H., Marklund, M., et al. (2004). Treatment of snoring and obstructive sleep apnea with mandibular repositioning appliances. Sleep Medicine Reviews, 8, 443–457.
Gotsopoulos, H., Kelly, J. J., & Cistulli, P. A. (2004). Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep, 27, 934–941.
Andren, A., Sjoquist, M., & Tegelberg, A. (2009). Effects on blood pressure after treatment of obstructive sleep apnoea with a mandibular advancement appliance—a 3-year follow-up. Journal of Oral Rehabilitation, 36, 719–725.
Otsuka, R., Ribeiro de Almeida, F., Lowe, A. A., et al. (2006). The effect of oral appliance therapy on blood pressure in patients with obstructive sleep apnea. Sleep & Breathing, 10, 29–36.
Barnes, M., McEvoy, R. D., Banks, S., et al. (2004). Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. American Journal of Respiratory and Critical Care Medicine, 170, 656–664.
Yoshida, K. (2006). Effect on blood pressure of oral appliance therapy for sleep apnea syndrome. The International Journal of Prosthodontics, 19, 61–66.
Coruzzi, P., Gualerzi, M., Bernkopf, E., et al. (2006). Autonomic cardiac modulation in obstructive sleep apnea: effect of an oral jaw-positioning appliance. Chest, 130, 1362–1368.
Kribbs, N. B., Pack, A. I., Kline, L. R., et al. (1993). Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. The American Review of Respiratory Disease, 147, 887–895.
Krieger, J., & Kurtz, D. (1988). Objective measurement of compliance with nasal CPAP treatment for obstructive sleep apnoea syndrome. The European Respiratory Journal, 1, 436–438.
Rauscher, H., Formanek, D., Popp, W., et al. (1993). Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest, 103, 1675–1680.
Gagnadoux, F., Fleury, B., Vielle, B., et al. (2009). Titrated mandibular advancement versus positive airway pressure for sleep apnoea. The European Respiratory Journal, 34, 914–920.
Schwartz, A. R., Thut, D. C., Russ, B., et al. (1993). Effect of electrical stimulation of the hypoglossal nerve on airflow mechanics in the isolated upper airway. The American Review of Respiratory Disease, 147, 1144–1150.
Miki, H., Hida, W., Shindoh, C., et al. (1989). Effects of electrical stimulation of the genioglossus on upper airway resistance in anesthetized dogs. The American Review of Respiratory Disease, 140, 1279–1284.
Schwartz, A. R., Bennett, M. L., Smith, P. L., et al. (2001). Therapeutic electrical stimulation of the hypoglossal nerve in obstructive sleep apnea. Archives of Otolaryngology—Head & Neck Surgery, 127, 1216–1223.
Kezirian, E. J., Boudewyns, A., Eisele, D. W., et al. (2010). Electrical stimulation of the hypoglossal nerve in the treatment of obstructive sleep apnea. Sleep Medicine Reviews, 14(5), 299–305.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vanderveken, O.M., Boudewyns, A., Ni, Q. et al. Cardiovascular Implications in the Treatment of Obstructive Sleep Apnea. J. of Cardiovasc. Trans. Res. 4, 53–60 (2011). https://doi.org/10.1007/s12265-010-9238-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-010-9238-y